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Data provided here are related to the research article entitled as ‘A
recombinant fusion protein-based, ﬂuorescent protease assay for
high throughput-compatible substrate screening’. Here we
describe data related to the investigation of the properties of the
His6-MBP-VSQNY↓PIVQ-mApple recombinant protein substrate
and its interactions with Ni-NTA magnetic beads, including the
dependence of substrate attachment on incubation time and
concentration. Data on the folding efﬁciency and conformational
stability of the recombinant substrate assessed by tryptic digestion
are also presented. We describe here the changes of ﬂuorescent
properties and binding abilities upon treatments commonly used
for stopping enzymatic reactions: trichloroacetic acid (TCA) or heat
treatment.
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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Dubject area Biology
ore speciﬁc subject area Biochemistry, Recombinant Proteins, Enzymatic assays and analysis
ype of data Figure (SDS-PAGE image), graph
ow data was acquired SDS-PAGE, Fluorimetry (Biotek Synergy2 multimode plate reader),
Densitometry
ata format Analyzed
xperimental factors Puriﬁed His6-MBP-VSQNY↓PIVQ-mApple recombinant fusion protein
substrate in cleavage buffer (50mM sodium-acetate, 300mM NaCl, 0.05%
Tween 20, pH 7.0)xperimental features Tryptic digestion and binding tests of untreated and treated His6-MBP-
VSQNY↓PIVQ-mApple to Ni-NTA magnetic agarose beadsata source location not applicable
ata accessibility Data is with this article.D
Value of the data
 Data from tryptic digestion may provide useful information on the folding properties of the
ﬂuorescent substrates
 In the case of homogenous protease assays, solution phase extraction may be used to remove
substrates and N-terminal cleavage fragments from reaction mixture, the dependence of binding
efﬁciency on the concentration of the applied magnetic beads and the incubation time need to be
optimized for efﬁcient attachment
 Exploring the changes in the binding abilities and ﬂuorescent properties of His6-MBP-VSQNY↓-
PIVQ-mApple recombinant protein upon TCA- treatment or heat-denaturation may provide valu-
able data for the methods used to stop enzyme reactions in the case of a homogenous assay
protocol1. Data
Data presented in this article provide information on characteristics of the His6-MBP-VSQNY↓-
PIVQ-mApple recombinant protein substrate (His6, hexahistidine tag; MBP, maltose binding protein;
VSQNY↓PIVQ, arrow indicates cleavage position within the sequence of the matrix and capsid clea-
vage site of human immunodeﬁciency virus type 1 protease). This recombinant protein have been
developed for a high throughput-compatible ﬂuorescent protease assay [1], investigated properties
(shown in Figs. 1–4) of this substrate are important determinants of its usability.2. Experimental design, materials and methods
All materials were purchased from Sigma-Aldrich (St Louis, MO, USA) unless otherwise indicated.
2.1. Substrate digestion by trypsin
Digestion of puriﬁed His6-MBP-VSQNY↓PIVQ-mApple recombinant substrate by trypsin was per-
formed by incubating the reaction mixture in 0.1M Tris buffer (1mM CaCl2, 0.05% Tween 20, pH 8.0)
at 37 °C for different incubation times. Reactions were stopped by the addition of loading buffer (6 ×
loading buffer, containing 12% SDS and 100mM β-mercaptoethanol) to reaction mixtures followed by
heat-treatment (incubation at 95 °C for 10min). Separation of the substrates and cleavage products
was carried out by denaturing SDS-PAGE using 14% polyacrylamide gel. The electrophoresis was
Fig. 2. Dependence of substrate binding to the Ni-NTA coated magnetic beads on bead concentration. The dependence of His6-
MBP-VSQNY↓PIVQ-mApple recombinant substrate attachment to Ni-NTA coated magnetic beads on bead concentration is
shown in the graph. Magnetic bead suspensions were set to different concentrations and were incubated with constant amount
of puriﬁed substrate. Fluorescence of both supernatant and eluate fractions were measured and plotted against bead con-
centration. Eluate fractions contain the bead-attached molecules, while supernatant fractions contain the molecules remained
in the solution. Fluorescent backgrounds of the supernatant fraction samples are caused by the presence of small amount of
free mApple in the substrate solution. Error bars represent SD (n ¼ 2).
Fig. 1. Digestion of His6-MBP-VSQNY↓PIVQ-mApple substrate by trypsin. The recombinant His6-MBP-VSQNY↓PIVQ-mApple
substrate was incubated with trypsin up to 60minutes. Samples were analyzed by SDS-PAGE, and the full-length His6-MBP-
VSQNY↓PIVQ-mApple substrate and mApple ﬂuorescent protein-containing C-terminal fragments were detected by UV ima-
ging (A). The band intensities for mApple were plotted as a function of incubation time (B).
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proteins. The ﬂuorescent proteins in the unstained gels were detected by UV imaging using AlphaI-
mager gel documentation system (ProteinSimple). Densitometry of gels was performed by using
GelAnalyzer 2010a program (www.gelanalyzer.com).
Preparation of trypsin was performed based on the methods described previously [2–4].
2.2. Analysis of magnetic bead concentration-dependence of substrate binding
His6-MBP-VSQNY↓PIVQ-mApple recombinant substrate was incubated with Ni-NTA coated mag-
netic beads (Qiagen) at 37 °C for 20min. Magnetic bead suspensions were added to the puriﬁed
substrate solution in different concentrations, ranging from 0–25% (v/v). Magnetic beads were sus-
pended in cleavage buffer (50mM sodium acetate, 300mM NaCl, 0.05% Tween 20, pH 7.0). The ﬁnal
volume of the solutions was set to 70μl. After incubation the solutions were placed onto Dyna-
magTM-2 magnetic particle concentrator (Thermo Fischer Scientiﬁc, Invitrogen) and the supernatants
were removed from the beads (supernatant fractions). To prepare eluate fractions the bead-attached
Fig. 3. Dependence of substrate binding to the Ni-NTA coated magnetic beads on incubation time. The dependence of His6-
MBP-VSQNY↓PIVQ-mApple recombinant substrate attachment to Ni-NTA coated magnetic beads on incubation time is
represented. Magnetic bead concentration was set to be constant, while the time of incubation was changed from 0 to
30minutes. Eluate fractions contain the bead-attached molecules, while supernatant fractions contain the molecules remained
in the solution. Supernatant and eluate fractions were analyzed by denaturing SDS-PAGE, and both full-length His6-MBP-
VSQNY↓PIVQ-mApple substrate (shown by black arrow) and mApple ﬂuorescent protein (white arrow) were detected by UV
imaging (A and B). Fluorescence of supernatant and eluate fractions were measured and plotted against incubation time (C).
Fluorescent backgrounds of the supernatant fraction samples are caused by the presence of small amount of free mApple in the
substrate solution. Error bars represent SD (n ¼ 2).
Fig. 4. Effect of trichloroacetic acid (TCA) and heat-denaturation on substrate binding to Ni-NTA coated magnetic beads. To test
the possible effects of two methods widely used for stopping enzymatic reactions on recombinant substrate properties, the
pre-treatment of the His6-MBP-VSQNY↓PIVQ-mApple protein by TCA and by heat was performed. Eluate fractions contain the
bead-attached molecules, while supernatant fractions contain the molecules remained in the solution. Relative ﬂuorescence
values were expressed as ﬂuorescence relative to that obtained for the untreated substrate. Error bars represent SD (n ¼ 2).
J.A. Mótyán et al. / Data in Brief 18 (2018) 203–208206
J.A. Mótyán et al. / Data in Brief 18 (2018) 203–208 207molecules were eluted from the beads by incubation in 70μl elution buffer (100mM EDTA, 0.05%
Tween 20, pH 8.0) for 10min at room temperature. The ﬂuorescence of both the supernatant and
eluate fractions were measured by using Biotek Synergy2 multimode plate reader at 590/35 nm
excitation and 645/40 nm emission wavelengths.
2.3. Analysis of time-dependence of substrate binding
His6-MBP-VSQNY↓PIVQ-mApple recombinant substrate was incubated with Ni-NTA coated mag-
netic beads (Qiagen) at 37 °C for different times. Concentration of the applied magnetic bead sus-
pension was set to be 5% (v/v), according to the manufacturer's protocol. The magnetic beads were
suspended in cleavage buffer. After the incubation, the solutions were removed from the beads
(supernatant fractions), and to prepare eluate fractions the bead-attached molecules were eluted
from the beads by incubation in 70μl elution buffer for 10min at room temperature. The ﬂuorescence
of both supernatant and eluate fractions were measured by using Biotek Synergy2 multimode plate
reader at 590/35 nm excitation and 645/40 nm emission wavelengths, followed by denaturing SDS-
PAGE analysis of the samples using 14% polyacrylamide gel. To renature the proteins, after electro-
phoresis the SDS was washed out by rinsing the gels in distilled water for 60minutes at room
temperature. The ﬂuorescent proteins in the unstained gels were detected by UV imaging using
AlphaImager gel documentation system (ProteinSimple).
2.4. Effect of TCA- or heat-treatment on substrate binding
The His6-MBP-VSQNY↓PIVQ-mApple recombinant substrate was dissolved in cleavage buffer. In
the case of TCA treatment, the TCA was added to the substrate solution in 5% (v/v) ﬁnal concentration,
and after centrifugation the precipitate was dissolved in cleavage buffer. In the case of heat-treatment,
substrate solution was incubated at 95 °C for 10min, followed by centrifugation and analysis of the
soluble fraction of the sample. Both treatments were followed by incubation of the samples with 5%
(v/v) magnetic bead suspension at 37 °C for 20min, then the solutions were removed from the beads
(supernatant fractions), and to prepare eluate fractions the bead-attached molecules were eluted by
incubation of the beads in 70μl elution buffer for 10min at room temperature. The ﬂuorescence of
both supernatant and eluate fractions were measured by using Biotek Synergy2 multimode plate
reader at 590/35 nm excitation and 645/40 nm emission wavelengths.Acknowledgments
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